Xylem Inc. (LON:0M29)
London · Delayed Price · Currency is GBP · Price in USD 132.08
-7.99 (-5.70%)
Feb 10, 2026, 4:47 PM GMT
Xylem Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,035 | 8,562 | 7,364 | 5,522 | 5,195 | |
Revenue Growth (YoY) | 5.52% | 16.27% | 33.36% | 6.30% | 6.54% |
Cost of Revenue | 5,560 | 5,350 | 4,647 | 3,438 | 3,220 |
Gross Profit | 3,475 | 3,212 | 2,717 | 2,084 | 1,975 |
Selling, General & Admin | 1,923 | 1,861 | 1,623 | 1,227 | 1,193 |
Research & Development | 226 | 230 | 232 | 206 | 204 |
Operating Expenses | 2,149 | 2,091 | 1,855 | 1,433 | 1,397 |
Operating Income | 1,326 | 1,121 | 862 | 651 | 578 |
Interest Expense | -29 | -44 | -49 | -50 | -76 |
Interest & Investment Income | - | 28 | 28 | 16 | 7 |
Earnings From Equity Investments | - | -4 | - | - | 9 |
Other Non Operating Income (Expenses) | 18 | -8 | 5 | -9 | -2 |
EBT Excluding Unusual Items | 1,315 | 1,093 | 846 | 608 | 516 |
Merger & Restructuring Charges | -95 | -105 | -206 | -15 | -6 |
Gain (Loss) on Sale of Investments | - | 152 | - | - | - |
Gain (Loss) on Sale of Assets | -31 | -46 | -1 | 1 | 2 |
Asset Writedown | -8 | -7 | -4 | -14 | -1 |
Other Unusual Items | - | - | - | -140 | - |
Pretax Income | 1,181 | 1,087 | 635 | 440 | 511 |
Income Tax Expense | 231 | 197 | 26 | 85 | 84 |
Earnings From Continuing Operations | 950 | 890 | 609 | 355 | 427 |
Minority Interest in Earnings | 7 | - | - | - | - |
Net Income | 957 | 890 | 609 | 355 | 427 |
Net Income to Common | 957 | 890 | 609 | 355 | 427 |
Net Income Growth | 7.53% | 46.14% | 71.55% | -16.86% | 68.11% |
Shares Outstanding (Basic) | 243 | 243 | 217 | 180 | 180 |
Shares Outstanding (Diluted) | 244 | 244 | 218 | 181 | 182 |
Shares Change (YoY) | 0.20% | 11.62% | 20.55% | -0.30% | 0.24% |
EPS (Basic) | 3.93 | 3.67 | 2.81 | 1.97 | 2.37 |
EPS (Diluted) | 3.92 | 3.65 | 2.79 | 1.96 | 2.35 |
EPS Growth | 7.40% | 30.82% | 42.35% | -16.60% | 67.86% |
Free Cash Flow | 873 | 942 | 566 | 388 | 330 |
Free Cash Flow Per Share | 3.58 | 3.87 | 2.59 | 2.14 | 1.82 |
Dividend Per Share | 1.600 | 1.440 | 1.320 | 1.200 | 1.120 |
Dividend Growth | 11.11% | 9.09% | 10.00% | 7.14% | 7.69% |
Gross Margin | 38.46% | 37.52% | 36.90% | 37.74% | 38.02% |
Operating Margin | 14.68% | 13.09% | 11.71% | 11.79% | 11.13% |
Profit Margin | 10.59% | 10.39% | 8.27% | 6.43% | 8.22% |
Free Cash Flow Margin | 9.66% | 11.00% | 7.69% | 7.03% | 6.35% |
EBITDA | 1,901 | 1,683 | 1,298 | 890 | 824 |
EBITDA Margin | 21.04% | 19.66% | 17.63% | 16.12% | 15.86% |
D&A For EBITDA | 575 | 562 | 436 | 239 | 246 |
EBIT | 1,326 | 1,121 | 862 | 651 | 578 |
EBIT Margin | 14.68% | 13.09% | 11.71% | 11.79% | 11.13% |
Effective Tax Rate | 19.56% | 18.12% | 4.09% | 19.32% | 16.44% |
Revenue as Reported | 9,035 | 8,562 | 7,364 | 5,522 | 5,195 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.